BIOMAT Database Logo BIOMAT Database Logo

Stereoselective synthesis and structure-activity relationship of novel ceramide trafficking inhibitors. (1R,3R)-N-(3-hydroxy-1-hydroxymethyl-3-phenylpropyl)dodecanamide and its analogues. 2003

Yoshitaka Nakamura, and Ryosuke Matsubara, and Hidetoshi Kitagawa, and Shū Kobayashi, and Keigo Kumagai, and Satoshi Yasuda, and Kentaro Hanada
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyou-ku, Tokyo 113-0033, Japan.

New ceramide trafficking inhibitors, (1R,3R)-N-(3-hydroxy-1-hydroxymethyl-3-phenylpropyl)dodecanamide (HPA-12) and a series of its analogues, were synthesized in diastereomerically and enantiomerically pure forms, and the structure-activity relationship was investigated. These analogues were stereoselectively synthesized via catalytic enantioselective Mannich-type reactions using a Cu(II)-chiral diamine 4 complex. Analysis of HPA-12 analogues having various lengths of the amide side chain showed that the optimal chain length for the inhibition of sphingomyelin biosynthesis is 13 with an IC(50) of approximately 50 nM. Masking of the hydroxy group at the 2'- or 3-position of HPA-12 was carried out by methylation, and it was revealed that these hydroxy groups were essential for the activity. Installation of another hydroxy group onto HPA-12 at the same position as that in the natural ceramide was also conducted, but no enhancement of the activity was observed.

UI MeSH Term Description Entries
D002518 Ceramides Members of the class of neutral glycosphingolipids. They are the basic units of SPHINGOLIPIDS. They are sphingoids attached via their amino groups to a long chain fatty acyl group. They abnormally accumulate in FABRY DISEASE. Ceramide
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D013109 Sphingomyelins A class of sphingolipids found largely in the brain and other nervous tissue. They contain phosphocholine or phosphoethanolamine as their polar head group so therefore are the only sphingolipids classified as PHOSPHOLIPIDS. Sphingomyelin
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D016466 CHO Cells CELL LINE derived from the ovary of the Chinese hamster, Cricetulus griseus (CRICETULUS). The species is a favorite for cytogenetic studies because of its small chromosome number. The cell line has provided model systems for the study of genetic alterations in cultured mammalian cells. CHO Cell,Cell, CHO,Cells, CHO

Related Publications

Yoshitaka Nakamura, and Ryosuke Matsubara, and Hidetoshi Kitagawa, and Shū Kobayashi, and Keigo Kumagai, and Satoshi Yasuda, and Kentaro Hanada
Stereoselective synthesis of (1R,2S,3R)-camphordiamine.
July 2000, The Journal of organic chemistry,
Yoshitaka Nakamura, and Ryosuke Matsubara, and Hidetoshi Kitagawa, and Shū Kobayashi, and Keigo Kumagai, and Satoshi Yasuda, and Kentaro Hanada
Novel anti-viability ceramide analogs: design, synthesis, and structure-activity relationship studies of substituted (S)-2-(benzylideneamino)-3-hydroxy-N-tetradecylpropanamides.
July 2010, Bioorganic & medicinal chemistry,
Yoshitaka Nakamura, and Ryosuke Matsubara, and Hidetoshi Kitagawa, and Shū Kobayashi, and Keigo Kumagai, and Satoshi Yasuda, and Kentaro Hanada
Synthesis and in vitro antitumor activity of novel acylspermidine derivative N-(4-aminobutyl)-N-(3-aminopropyl)-8-hydroxy-dodecanamide (AAHD) against HepG2 cells.
July 2019, Bioorganic chemistry,
Yoshitaka Nakamura, and Ryosuke Matsubara, and Hidetoshi Kitagawa, and Shū Kobayashi, and Keigo Kumagai, and Satoshi Yasuda, and Kentaro Hanada
Stereoselective cathodic synthesis of 8-substituted (1R,3R,4S)-menthylamines.
January 2015, Beilstein journal of organic chemistry,
Yoshitaka Nakamura, and Ryosuke Matsubara, and Hidetoshi Kitagawa, and Shū Kobayashi, and Keigo Kumagai, and Satoshi Yasuda, and Kentaro Hanada
Structure-activity relationship studies of highly selective inhibitors of the dopamine transporter: N-benzylpiperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine.
April 2003, Journal of medicinal chemistry,
Yoshitaka Nakamura, and Ryosuke Matsubara, and Hidetoshi Kitagawa, and Shū Kobayashi, and Keigo Kumagai, and Satoshi Yasuda, and Kentaro Hanada
(1R,3R,4S)-1-benzyl-3-(tert-butyldimethylsilyloxy)-4-(hydroxymethyl)pyrrolidine-borane: novel B-H...H-O hydrogen bonding.
August 2010, Acta crystallographica. Section C, Crystal structure communications,
Yoshitaka Nakamura, and Ryosuke Matsubara, and Hidetoshi Kitagawa, and Shū Kobayashi, and Keigo Kumagai, and Satoshi Yasuda, and Kentaro Hanada
Synthesis and Structure-Activity Relationship of Xenocoumacin 1 and Analogues as Inhibitors of Ribosomal Protein Synthesis.
March 2021, ChemMedChem,
Yoshitaka Nakamura, and Ryosuke Matsubara, and Hidetoshi Kitagawa, and Shū Kobayashi, and Keigo Kumagai, and Satoshi Yasuda, and Kentaro Hanada
Design, Synthesis and Structure-Activity Relationship Studies of Novel 4 (1-adamantyl) Phenyl Analogues as HIF-1α Inhibitors.
January 2016, Medicinal chemistry (Shariqah (United Arab Emirates)),
Yoshitaka Nakamura, and Ryosuke Matsubara, and Hidetoshi Kitagawa, and Shū Kobayashi, and Keigo Kumagai, and Satoshi Yasuda, and Kentaro Hanada
Synthesis, biological profile, and quantitative structure-activity relationship of a series of novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
November 1990, Journal of medicinal chemistry,
Yoshitaka Nakamura, and Ryosuke Matsubara, and Hidetoshi Kitagawa, and Shū Kobayashi, and Keigo Kumagai, and Satoshi Yasuda, and Kentaro Hanada
Potent and selective ligands for the dopamine transporter (DAT): structure-activity relationship studies of novel 4-[2-(diphenylmethoxy)ethyl]-1-(3-phenylpropyl)piperidine analogues.
February 1998, Journal of medicinal chemistry,
Copied contents to your clipboard!